Authors
This paper describes the synthesis and the biodegradation of optically active copolymers, poly[( R )-1-methyltrimethylene carbonate- co -ε-caprolactone] and poly[( S )-1-methyltrimethylene carbonate- co -ε-caprolactone] and poly[( R, R )-1,3-dimethyltrimethylene carbonate- co -ε-caprolactone] and poly[( S, S )-1,3-dimethyltrimethylene carbonate- co -ε-caprolactone]. The copolymers were prepared using a novel organolanthanide or AlEt 3 −H 2 O as the polymerization initiators, and their biodegradation by various enzymes and acclimated activated sludges was studied as a function of their composition, stereochemistry, crystallinity, T g (glass transition temperature), T m (melting point), molecular weight, and polydispersity. The copolymers synthesized exhibited high molecular weights with rather narrow molecular weight distributions and produced thermoplastic films when ( R )-1-MTC (1-MTC = 1-methyltrimethylene carbonate) or ( R, R )-1,3-DTC (1,3-DTC = 1,3-dimethyltrimethylene carbonate) content is less than 50 mol %. Optically active and racemic copolymers prepared using 1-MTC/CL (CL = ε-caprolactone) ratios of 17/83 to 19/81 were effectively biodegraded by lipoprotein lipase, cholesterol esterase and activated sludge. For the copolymers prepared using various 1,3-DTC/CL ratios, the poly( rac- 1,3-DTC- co -CL) was biodegraded faster than the poly[( R, R )-1,3-DTC- co- CL] and poly[( S, S )-1,3-DTC- co -CL] copolymers regardless of the 1,3-DTC/CL ratio. Biodegradation of all of these copolymers generated numerous cavities on the outermost surface of polymer films or solid masses without changing their molecular weight and polydispersity.
No takes yet. Share an insight, caveat, or question.
Yasuda et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: